Publicaciones en colaboración con investigadores/as de Hospital Xeral Calde (32)

2015

  1. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

    Thrombosis Journal, Vol. 13, Núm. 1

2012

  1. Initial experience with EUS-guided cholangiopancreatography for biliary and pancreatic duct drainage: A Spanish national survey

    Gastrointestinal Endoscopy, Vol. 76, Núm. 6, pp. 1133-1141

2011

  1. Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: Toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03)

    Leukemia and Lymphoma, Vol. 52, Núm. 3, pp. 409-416

2009

  1. Neuroprotección en la enfermedad de parkinson: Análisis a través de la metodología de informadores clave

    Neurologia, Vol. 24, Núm. 2, pp. 113-124

2008

  1. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

    Current Medical Research and Opinion, Vol. 24, Núm. 10, pp. 2931-2942

  2. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Clinical outcome of patients with venous thromboembolism and renal insufficiency. Findings from the RIETE registry

    Thrombosis and Haemostasis, Vol. 98, Núm. 4, pp. 771-776

  2. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

  3. Haemodynamically unstable pulmonary embolism in the RIETE Registry: Systolic blood pressure or shock index?

    European Respiratory Journal, Vol. 30, Núm. 6, pp. 1111-1116

2006

  1. Directrices "guidelines" de sedación/analgesia en endoscopia

    Revista Espanola de Enfermedades Digestivas, Vol. 98, Núm. 9, pp. 685-692

  2. Periannular Complications in Infective Endocarditis Involving Native Aortic Valves

    American Journal of Cardiology, Vol. 98, Núm. 9, pp. 1254-1260

  3. Periannular Complications in Infective Endocarditis Involving Prosthetic Aortic Valves

    American Journal of Cardiology, Vol. 98, Núm. 9, pp. 1261-1268

2005

  1. Aorto-cavitary fistulous tract formation in infective endocarditis: Clinical and echocardiographic features of 76 cases and risk factors for mortality

    European Heart Journal, Vol. 26, Núm. 3, pp. 288-297

  2. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells

    Haematologica, Vol. 90, Núm. 1, pp. 54-59

2004

  1. Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: The GEL/TAMO experience

    Annals of Oncology, Vol. 15, Núm. 10, pp. 1504-1509

  2. CD34 + cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance - Associated phenotypes

    Clinical Cancer Research, Vol. 10, Núm. 22, pp. 7599-7606

2003

  1. Audiovestibular manifestations in giant cell arteritis: A prospective study

    Medicine, Vol. 82, Núm. 1, pp. 13-26

  2. High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish cooperative group

    Annals of Oncology, Vol. 14, Núm. 1, pp. 140-151

  3. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051

  4. Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial

    British Journal of Haematology, Vol. 120, Núm. 2, pp. 296-303